Profil bibliographique

Michael Smyth

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

65Publications signalées

1611Citations signalées

1Affiliations récentes

Les institutions déclarées

BC Children's Hospital

Les domaines associés

Inflammatory Bowel DiseaseMicroscopic ColitisBiosimilars and Bioanalytical MethodsParathyroid Disorders and TreatmentsEosinophilic Esophagitis

Les publications récentes

2025 conference-abstract OpenAlex

OS-036 A multicentre randomised double-blind placebo-controlled phase 1b clinical trial evaluating the safety and mechanism of action of EBX-102, an oral pooled intestinal microbiota product, in liver cirrhosis: the IMPuLCE trial

Laura J. Craven, Michael Smyth, Lindsey Edwards, Debbie L. Shawcross et autres

0 citations Journal of Hepatology

2025 article OpenAlex

987b: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE II TRIAL ASSESSING THE SAFETY AND EFFICACY OF EBX-102-02, AN ORAL FULL-SPECTRUM INTESTINAL MICROBIOTA PRODUCT, IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION; THE TRIUMPH TRIAL

Laura J. Craven, Michael Smyth, Anthony Hobson, Robert E. Spiller et autres

0 citations Gastroenterology

2025 conference-abstract OpenAlex

P0693 The Chicago Mesenteric Fat Index: A Novel Biomarker for Assessing Inflammation in Pediatric Crohn’s Disease with Point of Care Intestinal Ultrasound

Amelia Kellar, Tari Magdy Aziz George, Michael T. Dolinger, Michael Smyth et autres

us, ca (code pays fourni par la source)

1 citation Journal of Crohn s and Colitis

Accès ouvert 2023 article OpenAlex

The incidence of remission and indicators of inadequate response to advanced therapy in patients with ulcerative colitis: results from medical charts in the United Kingdom

James O. Lindsay, Nils Picker, Daniel Kromer, Michael Smyth et autres

gb, de, be (code pays fourni par la source)

15 citations Current Medical Research and Opinion

Accès ouvert 2023 dataset OpenAlex

The incidence of remission and indicators of inadequate response to advanced therapy in patients with ulcerative colitis: results from medical charts in the United Kingdom

James O. Lindsay, Nils Picker, Daniel Kromer, Michael Smyth et autres

0 citations Figshare

Accès ouvert 2023 dataset OpenAlex

The incidence of remission and indicators of inadequate response to advanced therapy in patients with ulcerative colitis: results from medical charts in the United Kingdom

James O. Lindsay, Nils Picker, Daniel Kromer, Michael Smyth et autres

0 citations Figshare

2022 conference-abstract OpenAlex

P389 Indicators for inadequate response to advanced therapy in patients with Ulcerative Colitis: results from a medical chart review in the United Kingdom

James O. Lindsay, Nils Picker, Daniel Kromer, Michael Smyth et autres

gb, de, be (code pays fourni par la source)

0 citations Journal of Crohn s and Colitis

Accès ouvert 2020 review OpenAlex

Burden of disease associated with X-linked hypophosphataemia in adults: a systematic literature review

Lothar Seefried, Michael Smyth, Richard Keen, Pol Harvengt

de, gb (code pays fourni par la source)

81 citations Osteoporosis International

Accès ouvert 2020 article OpenAlex

The international X-linked hypophosphataemia (XLH) registry (NCT03193476): rationale for and description of an international, observational study

Raja Padidela, Ola Nilsson, Outi Mäkitie, Signe Sparre Beck‐Nielsen et autres

gb, se, fi, dk, es, de, it, nl, be, cn (code pays fourni par la source)

51 citations Orphanet Journal of Rare Diseases

Accès ouvert 2019 article OpenAlex

Vedolizumab use in patients with inflammatory bowel diseases undergoing surgery: clinical trials and post-marketing experience

Bo Shen, Aimee Blake, Karen Lasch, Michael Smyth et autres

us, gb (code pays fourni par la source)

10 citations Gastroenterology report

Accès ouvert 2018 article OpenAlex

The number needed to treat and relevant between-trial comparisons of competing interventions

Jeroen P. Jansen, Javaria Mona Khalid, Michael Smyth, Haridarshan Patel

gb, us (code pays fourni par la source)

4 citations ClinicoEconomics and Outcomes Research

Accès ouvert 2018 erratum OpenAlex

Corrigendum: Exposure—efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn’s Disease

Maria Rosario, Jonathan French, Nathanael L. Dirks, Serap Sankoh et autres

us, it, gb, ca, at, es (code pays fourni par la source)

123 citations Journal of Crohn s and Colitis

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.